Community Research and Development Information Service - CORDIS

  • European Commission
  • CORDIS
  • Publications
  • Communication from the Commission to the Council, the European Parliament, the European Economic [...] on the mid term review of the Strategy on Life Sciences and Biotechnology, COM(2007) 175 final
FP7

Communication from the Commission to the Council, the European Parliament, the European Economic [...] on the mid term review of the Strategy on Life Sciences and Biotechnology, COM(2007) 175 final

Funded under: FP7-HEALTH

Abstract

Communication from the Commission to the Council, the European Parliament, the European Economic and Social Committee and the Committee of the Regions on the mid term review of the Strategy on Life Sciences and Biotechnology, COM(2007) 175 final

Life sciences and biotechnology is a fast-evolving area with direct or potential significance for European businesses and European policymakers. It plays an increasing and accepted role in the health sector, with the development of new techniques for treatments and disease prevention. The industrial landscape in Europe is steadily being transformed by the use of life sciences and biotechnology by a large number of industries, resulting in a wide range of products already on the market.

The "bio-economy" therefore has the potential to contribute to key EU policy goals and help address new challenges in relation to health, energy supplies, global warming or an ageing population. The knowledge and skills available in Europe leaves it well placed to exploit this potential both within Europe and on a global scale, including in its relations with developing countries.

Biotechnology is an important means to promote growth, jobs and competitiveness in the EU. The use of biotechnology is however not without controversy and the enhanced use of biotechnology needs to be accompanied by a broad societal debate about the potential risks and benefits of biotechnology including its ethical dimension.

The European Council and the European Parliament have recognised the importance of life sciences and biotechnology, and the Commission has put forward an action plan to address the challenges and opportunities involved. This Strategy on Life Sciences and Biotechnology, adopted by the Commission in 2002, proposed a 30 point action plan involving the Commission, the other European Institutions and other stakeholders. It runs until 2010.

Download application/pdf (53376)

Record Number: 8624 / Last updated on: 2007-07-02
Category: COM DOCUMENT